A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction

BACKGROUND: Tenofovir alafenamide (TAF) is associated with less renal and bone toxicity compared with tenofovir disoproxil (TDF). TAF's recent FDA approval has spurred HIV providers to consider switching antiretroviral therapy (ART) regimens containing TDF to TAF to minimize long term risks. Pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Lee, Sarah S., Havens, Joshua P., Sayles, Harlan R., O’Neill, Jennifer L., Podany, Anthony T., Swindells, Susan, Scarsi, Kimberly K., Bares, Sara H.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035459/
https://ncbi.nlm.nih.gov/pubmed/29980192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3226-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars